• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Encouraging Women to Utilize FDA Safe Medication Use Resources

Description: This project uses social media and traditional outreach activities to facilitate consumer access to quality, reliable information on FDA regulated products and issues of importance to women. OWH consumer publications and videos along with FDA product safety alerts will be disseminated to consumers, health professionals, advocates and other target audiences via digital outreach channels (FDA website, Twitter, Pinterest, You Tube) and the Federal Citizen Information Center).

Accomplishment: FY14 - OWH utilized a multipronged strategy (print publication distribution, digital outreach, stakeholder outreach) to encourage women to utilize FDA safe medication use resources and to provide women and women’s health professionals with information they can use to make informed decisions about the use of FDA regulated products. Working in collaboration with USA.gov, OWH distributed 6 million consumer publications in 2014 through the Federal Citizen Information Center and OWH outreach activities including four special promotions: (1) New Year – New You Promotion; (2) College Health/ Spring Break Promotion; (3) National Women’s Health Week Promotion; and (4) Healthy Aging Promotion. The materials were made available to consumers for personal use and to healthcare professionals, community based service providers, women’s organizations, and national associations for use in clinical services and health promotion activities. As a part of the digital outreach, OWH utilized Pinterest, Twitter, Email and the For Women section of FDA’s website to disseminate FDA risk communication alerts, consumer health messages, and program announcements to women’s health stakeholders. OWH participated in 5 twitter chats in priority areas: Medicine and Pregnancy, Minority Health, FDASIA 907 Action Plan, and National Women’s Health Week. OWH also increased @FDAWomen followers from 34,000 to 47,000 and increased the average number of engagements from 10 per tweet in 2013 to 16 per tweet in 2014. OWH launched FDA’s first Pinterest board and cultivated over 700 followers – the most of any FDA Pinterest board. OWH reached over 1.9 million users with 33 email alerts and monthly updates on FDA information and activities of interest to women. In addition, over 267,000 publications were downloaded through the For Women website. Lastly, OWH co-sponsored a stakeholder meeting to solicit input from health professionals, researchers, and consumers about pregnancy exposure registries and other studies of medication use during pregnancy. OWH co-sponsored with CDER and CBER the May 2014 Public Meeting: Study Approaches and Methods to Evaluate the Safety of Drugs and Biological Products during Pregnancy in the Post-Approval Setting.

FY14 Activities

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Obtain an OWH seat on the MedWatch council towards improving agency signal detection, such as from disease groups

FY14 Q2

Completed 3/31/2014

B. Conduct four publication promotions with USA.gov to disseminate print and electronic copies of FDA consumer information

FY14 Q3

Completed 5/19/2014

C. Conduct one workshop for women's health stakeholders

FY14 Q4

Completed 9/18/2014

D. Conduct one women's health Twitter chat

FY14 Q4

Completed 5/13/2014

E. Launch a women's health board on Pinterest and post at least two pins per month during the first year post-launch

FY14 Q4

Completed 9/30/2014

FY15 Activities

A. Pregnancy Outreach Initiative: The Pregnancy Initiative disseminates digital and print FDA resources on the use of medicines and other FDA-regulated products during pregnancy. OWH will collaborate with other FDA partners and external organizations to raise awareness about pregnancy exposure registries, pregnancy and lactation product labeling, food safety, and other FDA pregnancy-related resources.

Briefing Status: On Track

Prior Briefing Status: Not Yet Started

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Update Pregnancy Registry Web Listing

FY15 Q3

On Track

2. Promote Pregnancy Publication

FY15 Q4

On Track

3. Conduct Digital and Stakeholder Outreach Campaign

FY15 Q4

On Track

B. Women in Clinical Trials Campaign: OWH and the NIH Office of Research on Women’s Health are collaborating on a campaign to raise awareness of the importance of participation of diverse women in clinical trials and to share best practices about clinical research design, recruitment, and subpopulation analyses.

Briefing Status: On Track

Prior Briefing Status: Not Yet Started

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Hold stakeholder meeting or workshop

FY15 Q4

On Track

2. Conduct Education Outreach Campaign

FY16 Q4

Not Yet Started

C. "Take Time to Care" General Safe Medication Use Outreach: The project utilizes traditional and digital outreach activities to provide women with FDA consumer resources and other production information that can be used to make better informed decisions about the safe use of FDA-regulated products.

Briefing Status: On Track

Prior Briefing Status: Not Yet Started

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

1. Hold Women's Health Twitter chat

FY15 Q2

Completed 2/6/2015

2. Promote 4 publications with USA.gov

FY15 Q4

On Track

3. Post 2 pins per month on Pinterest

FY15 Q4

On Track

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.